218 related articles for article (PubMed ID: 12700401)
21. Influence of arylamine N-acetyltransferase, sex, and age on 4-aminobiphenyl-induced in vivo mutant frequencies and spectra in mouse liver.
Wang S; Sugamori KS; Brenneman D; Hsu I; Calce A; Grant DM
Environ Mol Mutagen; 2012 Jun; 53(5):350-7. PubMed ID: 22508569
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of liver drug-metabolizing enzymes in a murine model of chronic renal failure.
Dani M; Boisvert C; Michaud J; Naud J; Lefrançois S; Leblond FA; Pichette V
Drug Metab Dispos; 2010 Mar; 38(3):357-60. PubMed ID: 20007296
[TBL] [Abstract][Full Text] [Related]
23. Arylamine N-acetyltransferase activity in bronchial epithelial cells and its inhibition by cellular oxidants.
Dairou J; Petit E; Ragunathan N; Baeza-Squiban A; Marano F; Dupret JM; Rodrigues-Lima F
Toxicol Appl Pharmacol; 2009 May; 236(3):366-71. PubMed ID: 19248797
[TBL] [Abstract][Full Text] [Related]
24. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
[TBL] [Abstract][Full Text] [Related]
25. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder.
Badawi AF; Hirvonen A; Bell DA; Lang NP; Kadlubar FF
Cancer Res; 1995 Nov; 55(22):5230-7. PubMed ID: 7585581
[TBL] [Abstract][Full Text] [Related]
26. Acetylator genotype-dependent expression of arylamine N-acetyltransferase and N-hydroxyarylamine O-acetyltransferase in Syrian inbred hamster intestine and colon. Identity with the hepatic acetylation polymorphism.
Ogolla F; Ferguson RJ; Kirlin WG; Trinidad A; Andrews AF; Mpezo M; Hein DW
Drug Metab Dispos; 1990; 18(5):680-5. PubMed ID: 1981720
[TBL] [Abstract][Full Text] [Related]
27. N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland.
Sadrieh N; Davis CD; Snyderwine EG
Cancer Res; 1996 Jun; 56(12):2683-7. PubMed ID: 8665493
[TBL] [Abstract][Full Text] [Related]
28. The xenobiotic-metabolizing enzymes arylamine N-acetyltransferases in human lens epithelial cells: inactivation by cellular oxidants and UVB-induced oxidative stress.
Dairou J; Malecaze F; Dupret JM; Rodrigues-Lima F
Mol Pharmacol; 2005 Apr; 67(4):1299-306. PubMed ID: 15644493
[TBL] [Abstract][Full Text] [Related]
29. Cloned mouse N-acetyltransferases: enzymatic properties of expressed Nat-1 and Nat-2 gene products.
Martell KJ; Levy GN; Weber WW
Mol Pharmacol; 1992 Aug; 42(2):265-72. PubMed ID: 1513324
[TBL] [Abstract][Full Text] [Related]
30. NATb/NAT1*4 promotes greater arylamine N-acetyltransferase 1 mediated DNA adducts and mutations than NATa/NAT1*4 following exposure to 4-aminobiphenyl.
Millner LM; Doll MA; Cai J; States JC; Hein DW
Mol Carcinog; 2012 Aug; 51(8):636-46. PubMed ID: 21837760
[TBL] [Abstract][Full Text] [Related]
31. Only low levels of exogenous N-acetyltransferase can be achieved in transgenic mice.
Cao W; Chau B; Hunter R; Strnatka D; McQueen CA; Erickson RP
Pharmacogenomics J; 2005; 5(4):255-61. PubMed ID: 16041393
[TBL] [Abstract][Full Text] [Related]
32. Arylamine N-acetyltransferases. Expression in Escherichia coli, purification, and substrate specificities of recombinant hamster monomorphic and polymorphic isozymes.
Wagner CR; Bergstrom CP; Koning KR; Hanna PE
Drug Metab Dispos; 1996 Feb; 24(2):245-53. PubMed ID: 8742238
[TBL] [Abstract][Full Text] [Related]
33. Genotoxic activation of 2-phenylbenzotriazole-type compounds by human cytochrome P4501A1 and N-acetyltransferase expressed in Salmonella typhimurium umu strains.
Oda Y; Watanabe T; Terao Y; Nukaya H; Wakabayashi K
Mutat Res; 2008 Jun; 654(1):52-7. PubMed ID: 18562244
[TBL] [Abstract][Full Text] [Related]
34. Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene.
Cornish VA; Pinter K; Boukouvala S; Johnson N; Labrousse C; Payton M; Priddle H; Smith AJ; Sim E
Pharmacogenomics J; 2003; 3(3):169-77. PubMed ID: 12815365
[TBL] [Abstract][Full Text] [Related]
35. Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase.
Hein DW; Flammang TJ; Kirlin WG; Trinidad A; Ogolla F
Carcinogenesis; 1987 Dec; 8(12):1767-74. PubMed ID: 3677303
[TBL] [Abstract][Full Text] [Related]
36. Liver-selective expression of human arylamine N-acetyltransferase NAT2 in transgenic mice.
Sugamori KS; Brenneman D; Grant DM
Drug Metab Dispos; 2011 May; 39(5):882-90. PubMed ID: 21317369
[TBL] [Abstract][Full Text] [Related]
37. Arylamine N-acetyltransferase activity of the human placenta.
Derewlany LO; Knie B; Koren G
J Pharmacol Exp Ther; 1994 May; 269(2):756-60. PubMed ID: 8182542
[TBL] [Abstract][Full Text] [Related]
38. Kinetic characterization of acetylator genotype-dependent and -independent N-acetyltransferase isozymes in homozygous rapid and slow acetylator inbred hamster liver cytosol.
Trinidad A; Kirlin WG; Ogolla F; Andrews AF; Yerokun T; Ferguson RJ; Brady PK; Hein DW
Drug Metab Dispos; 1989; 17(3):238-47. PubMed ID: 2568903
[TBL] [Abstract][Full Text] [Related]
39. Human arylamine N-acetyltransferase 1: in vitro and intracellular inactivation by nitrosoarene metabolites of toxic and carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2008 Oct; 21(10):2005-16. PubMed ID: 18759501
[TBL] [Abstract][Full Text] [Related]
40. Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase.
Trinidad A; Hein DW; Rustan TD; Ferguson RJ; Miller LS; Bucher KD; Kirlin WG; Ogolla F; Andrews AF
Cancer Res; 1990 Dec; 50(24):7942-9. PubMed ID: 2253236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]